My not-very-long experience as a POCT director is that large things can drop unexpectedly into the realm of the POCT program from great administrative heights. Such was a recent occurrence at our institution regarding startup of thromboelastography (TEG). TEG is not unknown in POCT, and educational...(Read More)

The current regulatory landscape for clinical genomic testing is reminiscent of a twentieth century American saying, “Almost only counts in horseshoes and hand grenades”. Since there are no specific requirements in CLIA’88 for genetic testing, there has always been a wide variety in opinion for wha...(Read More)

A 52-year-old African American male with previously diagnosed type 2 diabetes mellitus and hemoglobin SC disease underwent transfusion therapy for treatment of an acute episode of sickle cell crisis. Post-transfusion hemoglobin electrophoresis was ordered to assess the percent of his total hemoglob...(Read More)

 In the November issue of AACC's Strategies publication, Mr. Bill Malone writes about "Improving Cardiovascular Risk Prediction" through the use of new lipid markers. The article's summary of the National Lipid Association's (NLA) expert panel (J Clin Lipidol 2011;5:338-367) is that for p...(Read More)